More than $80 million invested to expand and strengthen ESTEVE CDMO's manufacturing capabilities in China.Three manufacturing workshops and 250 m³ of total reaction volume, adding new capabilities to our global manufacturing network.More than 20 years of manufacturing presence in China, marking a new chapter in ESTEVE CDMO's long-term commitment to the country.SHAOXING, China, Oct. 21, 2026 /PRNewswire/ — ESTEVE CDMO, Esteve's Healthcare contract development and manufacturing organization, is strengthening its global manufacturing footprint through the relocation, expansion and modernization of its existing operations in China, with an investment of more than $80 million. Continue Reading Shaoxing Site Sun Xuejie The new facility…